Biologics and
Injectables Index

Convert Unblinded Payer Perceptions into Insights

Track current and emerging trends about biologics and injectables with perspectives from payers, HCPs, office managers, representing 75% of Commercial and Medicare lives. Capture unblinded payer perceptions to drive insightful action.

Learn More


Examine

Examine payer reactions to relevant topics affecting healthcare each quarter.

Assess

Assess high level payer management techniques, site of care dynamics, and administration burden via Access Management Topics.

Review

Review a deep dive of specific therapeutic areas, including analysis of disruptive events and payer perceptions of new or emerging therapies.

Understand

Understand perspectives from key payer stakeholders representing 75% of Commercial and Medicare lives.

Features

How We Help

MMIT's Biologics and Injectables Index gathers insights through field research with its industry-leading panel of pharmacy decision-makers at health plans, PBMs, providers and integrated delivery systems. 100% of panelists are either active P&T participants or control access for pharmaceuticals for their organizations, giving you unparalleled visibility into these entities.

Understand

Understand which biologic and injectable agents are more commonly prescribed by HCPs and their familiarity with upcoming launches.

Uncover

Uncover patient concerns that are most commonly discussed with their physician when looking for new starts on biologic and injectable therapies or when being forced to switch.

Increase Efficiency

Increase rebate processing team efficiency.

Reduce Leakage

Reduce rebate leakage and protect millions of dollars from leaving your organization due to incorrect formulary and medical benefit positioning.

Improve Reach

Conduct more comprehensive contract evaluation.

Review

Review Practice Manager and HCP perception of administration burden for each brand.

Observe

Observe anticipated coverage changes within a payer organization over time for its Commercial and Medicare lines of business.

Minimize Errors

Minimize data inaccuracies and human-made errors.

Slide 1
bridging-as-a-service-brochure
target-icon
desktop-data-icon
data-icon

Discover More About Biologics & Injectables Index

Improve decision making with a forward-looking analysis into access management topics and therapeutic area management, sourced directly from payers, HCPs, and practice managers representing 75% of Commercial & Medicare lives.

Slide 2

RELATED SOLUTIONS

Solutions to Support Your Strategy
oncology-index

Oncology Index

Leverage the MMIT Oncology Index to synthesize insights into an analysis of payer trends, oncology management, and disruptive market events.

message-monitor

Message Monitor

Use Message Monitor to capture key payer and IDN decision-makers’ insights around brand perception so you can better position your product against the competition.

Slide 2

RELATED SOLUTIONS

Solutions to Support Your Strategy
rapid-response

Rapid Response

Improve your brand strategy with Rapid Response’s quick, actionable answers to key business questions among a representative sample of the payer and IDN stakeholders that you care about.

pt-perspectives

P&T Perspectives

P&T Perspectives provides qualitative and tangible feedback through a simulated P&T session that informs your brand’s strategy and helps you determine how your product—or your competitor’s product—will fare in a real P&T Committee review.

previous arrowprevious arrow
previous arrowprevious arrow
next arrownext arrow
next arrownext arrow